Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Science (New York, N.Y.)|September 6, 2003
Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signalingWei Chen, Kellye C Kirkbride, Tam How, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 1, 1997
Report from the 1995 Core Indicators for Peritoneal Dialysis Study GroupM V Rocco, M J Flanigan, S Beaver, et al.
The Journal of Biological Chemistry|February 3, 2004
Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3Mark W Feinberg, Masafumi Watanabe, Maria A Lebedeva, et al.
Circulation Research|January 31, 2004
Essential role for Smad3 in regulating MCP-1 expression and vascular inflammationMark W Feinberg, Koichi Shimizu, Maria Lebedeva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Neisseria gonorrhoeae activates the proteinase cathepsin B to mediate the signaling activities of the NLRP3 and ASC-containing inflammasomeJoseph A Duncan, Xi Gao, Max Tze-Han Huang, et al.
Mbio|November 21, 2013
Lipid A's structure mediates Neisseria gonorrhoeae fitness during experimental infection of mice and menMarcia M Hobbs, James E Anderson, Jacqueline T Balthazar, et al.
Nucleic Acid Therapeutics|August 9, 2018
MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-DestructRuchi Jain, Josh P Frederick, Eric Y Huang, et al.
Science Translational Medicine|February 1, 2019
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAsSusannah L Hewitt, Ailin Bai, Dyane Bailey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor MicroenvironmentSusannah L Hewitt, Dyane Bailey, John Zielinski, et al.
Cancer Discovery|August 8, 2024
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 StudyJustin F Gainor, Manish R Patel, Jeffrey S Weber, et al.
Pageof 5